Dabur India Limited has informed the Exchange about Observation Letter with "no adverse observation" received from BSE Limited in relation to the Scheme of Amalgamation of Sesa Care Private Limited with and into Dabur India Limited
DABUR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dabur India Limited has received an observation letter with 'no adverse observation' from BSE Limited for its proposed merger with Sesa Care Private Limited. This is an important regulatory step in the amalgamation process where Sesa Care will merge into Dabur. The 'no adverse observation' from the stock exchange indicates that BSE does not see any issues with the scheme as proposed. The next step would typically involve filing the scheme with the National Company Law Tribunal (NCLT) for approval. No financial details, share swap ratio, or deal valuation have been disclosed in this particular filing.
Positive procedural development for Dabur shareholders, as it moves the Sesa Care amalgamation closer to completion. Share swap ratio and valuation details, when announced, will be key for assessing the deal's impact on shareholders.